Chronic hepatitis B infections on the rise since 2008
In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.
Use of, and likelihood of using, HIV pre-exposure prophylaxis among men who have sex with men in Europe and Central Asia: Findings from a 2017 large geosocial networking application survey
Bourne, A., Alba, B., Garner, A., Spiteri, G., Pharris, A., Noori, T.
Quantifying unmet prevention needs among msm in europe through a multi-site bio-behavioural survey
Mirandola, M., Gios, L., Sherriff, N., Marcus, U., Toskin, I., Rosinska, M., Schink, S., Kühlmann-Berenzon, S., Suligoi, B., Folch, C., Nöstlinger, C., Dias, S., Stanekova, D., Klavs, I., Caplinskas, S., Rafila, A., Marin, C., Alexiev, I., Zohrabyan, L., Noori, T., Menel-Lemos, C.
Ending the HIV epidemic: where does Europe stand?
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. The main issues: diagnosing those who are unaware of their HIV infection and treating them.
Infographic: HIV and AIDS in Europe 2017
Europe experiences a persistent HIV epidemic, with only little changes in notifications during the last decade in the EU/EEA. One reason for this: an estimated 120 000 Europeans are living with undiagnosed HIV in the EU/EEA, which means that about 1 in 5 (15 %) of those living with HIV are not aware of their status. And it takes around three years from HIV infection to diagnosis.
European Scientific Conference on Applied Infectious Disease Epidemiology 2018
The European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is an annual three-day scientific conference, open to the wider communicable disease surveillance community.
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
Plachouras, D., Kärki, T., Hansen, S., Hopkins, S., Lyytikäinen, O., Moro, M.L., Reilly, J., Zarb, P., Zingg, W., Kinross, P., Weist, K., Monnet, D.L., Suetens, C., The Point Prevalence Survey Study Group
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Ricchizzi, E., Latour, K., Kärki, T., Buttazzi, R., Jans, B., Moro, M.L., Nakitanda, O.A., Plachouras, D., Monnet, D.L., Suetens, C., Kinross, P., The Halt Study Group
Substantial heterogeneity in progress towards reaching the 90-90-90 HIV target in the WHO European Region
Porter,K., Gourlay, A., Attawell, K., Hales, D., Supervie, V., Touloumi, G., Rosinska, M., Vourli, G., van Sighem, A., Pharris, A., Noori, T.
World Hepatitis Day 2018
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.